Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Hypoaesthesia oral, Nasal congestion, Parosmia, Upper-airway cough syndrome
Clinical narrative: smell & taste became altered with a chemical and metallic taste/odor; smell & taste became altered with a chemical and metallic taste/odor; numb and thick-feeling tongue; Postnasal drip; Congestion; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 28Apr2021 15:00 (Lot number: EP6955) at the age of 52 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, Single, Lot number- EN6200, Vaccine location- Left arm, Administration Time- 15:00), administration date: 31Mar2021, when the patient was 52 years old, for COVID-19 Immunization, reaction(s): "My smell & taste became altered with a chemical and metallic taste/odor", "My smell & taste became altered with a chemical and metallic taste/odor", "Post nasal drip", "Congestion". The following information was reported: DYSGEUSIA (non-serious), PAROSMIA (non-serious) all with onset 28Apr2021, outcome "not recovered" and all described as "smell & taste became altered with a chemical and metallic taste/odor"; HYPOAESTHESIA ORAL (non-serious) with onset 28Apr2021, outcome "not recovered", described as "numb and thick-feeling tongue"; UPPER-AIRWAY COUGH SYNDROME (non-serious) with onset 2021, outcome "not recovered", described as "Postnasal drip"; NASAL CONGESTION (non-serious) with onset 2021, outcome "not recovered", described as "Congestion". Therapeutic measures were not taken as a result of dysgeusia, parosmia, hypoaesthesia oral, upper-airway cough syndrome, nasal congestion. Additional information: Patient did not receive any other vaccine in four weeks. Other medications in two weeks included just one-a-day women vitamin. Almost immediately after the first shot, her smell & taste became altered with a chemical and metallic taste/odor. This continued and immediately after the second shot, it became more intense for a few days on 28Apr2021. It has now been 2 months since the second shot and everything tasted and smelled this way - some things worse than others. She also had very thick/white post nasal drip (congestion) constantly since the first shot on an unspecified date in 2021. The taste/smell felt like it comes from that area-deep back of the throat. She also had a somewhat numb and thick-feeling tongue, but there was no visual indication of abnormality. None of this seemed to be improving. Patient did not receive any treatment for the adverse events. Patient did not have COVID-19, prior to vaccination. Patient was not tested for COVID-19, post vaccination. Other medical history and known allergies were reported as none. Facility where the most recent COVID-19 vaccine was administered was reported as Workplace clinic. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior to vaccination and was not tested for COVID-19, since the vaccination. Device Date was reported as 22Jun2021.   No follow-up attempts are possible. No further information is expected.  Follow-Up (21Jul2021): Follow-up attempts are completed. No further information is expected.